Bioyitech FIC 2026 | Clinical Evidence at the Core: Redefining the New Paradigm of Metabolic Health Microecological Solutions
The 28th China International Food Additives and Ingredients Exhibition (FIC 2026) successfully concluded from March 17 to 19, 2026, at the National Exhibition and Convention Center (Hongqiao) in Shanghai. Positioned as the “Metabolic Health Microecological Solution Expert,” Bioyitech made its debut at Booth 61A07 in Hall 6, focusing on the needs of populations with metabolic disorders such as hyperuricemia, diabetes, and obesity. Backed by clinical evidence from tertiary hospitals and its one-stop OEM/ODM service capabilities, the company stood out as a key player in the functional food and Probiotic Sectors at this year’s exhibition.
Clear Strategic Positioning: From “Raw Material Supplier” to “Clinical Evidence-Driven Solution Provider”
At this exhibition, Bioyitech clearly conveyed its core message: it does not engage in conceptual marketing but focuses solely on functional products supported by registered clinical data. The main visual of the booth emphasized the theme “Focus on Metabolism – Balancing ‘The Three Highs’ with Probiotics – Enhancing Health and Wellbeing,” and prominently displayed the clinical trial registration numbers (ChiCTR2500096029 / ChiCTR2400089551) of its two core products, reinforcing its professional credibility.
This strategy precisely aligns with current industry trends:
- Increasingly stringent regulations require scientific substantiation for efficacy claims;
- Consumers are becoming more rational and rejecting “pseudo-functional” products;
- Brands urgently need differentiated competitive advantages.
Through its integrated model combining “clinical data, application scenarios, and customized services,” Bioyitech successfully attracted a wide range of visitors, including dietary supplement companies, foods for special medical purposes (FSMP) manufacturers, emerging brands, and OEM enterprises, engaging them in in-depth discussions.
Core Products That Drew Significant Attention: A Dual-Star Combination Tackling Metabolic Pain Points
- Pruineed™ – Uric Acid-Reducing Probiotic
Targeting the over 180 million hyperuricemia patients in China, this product is backed by a randomized, double-blind, placebo-controlled trial demonstrating its effectiveness in significantly reducing serum uric acid levels (average reduction of 15%–22%) with a strong safety profile. Many clients on-site noted, “This is one of the few uric acid-reducing probiotic solutions in the market with complete human clinical data.” Its broad applicability spans functional beverages, solid drinks, FSMP products, and snack-like health products, meeting the development needs of various distribution channels. - SugaRite™ – Blood Glucose-Reducing Probiotic
Catering to nearly 500 million diabetes patients worldwide and a vast pre-diabetic population, SugaRite™ achieves a “three reductions and one stabilization” effect (lowering fasting blood glucose, postprandial blood glucose, and triglycerides, while stabilizing BMI). Its dual mechanism, involving “gut-pancreas axis regulation and fat metabolism intervention,” has been highly recognized by experts in nutrition. The product shows significant application potential in areas such as sugar-control meal replacements, low-GI staple foods, and diabetes-friendly dairy products.
A Core Breakthrough: Domestic Substitution for Supply Chain Autonomy
At this exhibition, Bioyitech’s strategy of promoting “domestically produced starter cultures” resonated strongly within the industry.
For a long time, the high-end starter culture market has been dominated by imported brands, leading to high costs and supply chain vulnerabilities. Leveraging its proprietary strain resource library, Bioyitech has successfully overcome several core technical challenges:
Excellent Aroma Production: Proprietary strains generate rich flavor compounds, broadening the flavor profiles of products;
Superior Functional Characteristics: Featuring high viscosity production, weak post-acidification, and strong tolerance to acid and bile salts;
Strong Adaptability: Perfectly compatible with various bases such as cow’s milk, oat milk, and various fruit and vegetable juices.
“Our goal is clear: to provide Chinese clients with world-class domestically produced starter cultures.”
By offering comprehensive solutions for plant-based and yogurt starter cultures, Bioyitech not only helps customers reduce costs but, more importantly, enhances supply chain security and autonomy. In a global environment filled with uncertainties, this assurance of “reliability” is particularly valuable.
Service Capabilities Highly Praised: Empowering Clients with Full-Chain Support
Beyond its products, Bioyitech’s one-stop OEM/ODM service capabilities emerged as another key highlight:
Strain Formulation Optimization: Customizing compound formulas based on target demographics and dosage form requirements;
Dosage Form Development & Stability Testing: Covering various formats such as powders, capsules, and tablets;
Regulatory Compliance Guidance: Assisting with registration filing, label review, and advertising copy compliance checks;
Market Positioning Support: Providing packaging design and selling point recommendations based on consumer insights;
Supply Chain Assurance: Utilizing in-house manufacturing and stable production capacity to ensure delivery timelines and consistent quality.
Looking Ahead: Harnessing the Power of Fermentation for a Healthier and Tastier Life
Although FIC 2026 has concluded, the exploration of metabolic health combined with optimal flavor is just accelerating.Through this exhibition, we are more convinced than ever that:
Clinical evidence is the cornerstone of functional foods;
The flavor experience is key to winning over consumers.